A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2006
11/29/2006	EP1725226A2 The treatment of inflammatory disorders and pain using beta-aminoalcohols
11/29/2006	EP1478381A4 Use of soluble gamma delta t cell receptors for regulating t cell function
11/29/2006	EP1401474B1 Methods for inducing sustained immune response
11/29/2006	EP1366080B1 Natural antibodies active against hiv virus
11/29/2006	EP1353953B1 Mu-1, member of the cytokine receptor family
11/29/2006	EP1248804B1 Recombinant antibodies to human interleukin-1 beta
11/29/2006	EP1248650B1 Improved dna vaccines for bovine herpesvirus-1
11/29/2006	EP1196598B1 Dsp-3 dual-specificity phosphatase
11/29/2006	EP1162999B1 Vaccine against Streptococcus pneumoniae
11/29/2006	EP1158993B1 Bacterial membrane fractions with adjuvant effect
11/29/2006	EP1117801B1 Polyketide synthase enzymes and recombinant dna constructs therefor, for the production of compounds related to fk-506 and fk-520
11/29/2006	EP1092027B1 Therapeutic and diagnostic domain 1 beta 2 gp1 polypeptides and methods of using same
11/29/2006	EP1079857B1 Combination meningitidis b/c vaccines
11/29/2006	EP1021406B1 Novel anandamide amidase inhibitors as analgesic agents
11/29/2006	EP1012281B1 Human leukocyte calcium activated potassium channel polypeptide
11/29/2006	EP0821695B1 Antibody purification by low-ph hydrophobic interaction chromatography
11/29/2006	EP0556292B2 Hepatitis c virus asialoglycoproteins
11/29/2006	CN1871240A Pyrrolopyrimidine thion derivatives
11/29/2006	CN1871015A Immunemodulating oligosaccharides
11/29/2006	CN1870992A 动物饲料组合物 Animal feed compositions
11/29/2006	CN1870910A Synbiotic composition for infants
11/29/2006	CN1869230A Nucleotid sequence of human interleukin 21 and method and application of producing matured human interleukin 21
11/29/2006	CN1869207A Rat antihuman macrephage migration inhibiting factor monoclone antibody and its application
11/29/2006	CN1868545A Improved vaccines
11/29/2006	CN1868538A Composition contg. scorpion protein and SOD used as food and medicine
11/29/2006	CN1868511A Compound prepn. contg. extractive of almond and extractive of ginkgo leaf
11/29/2006	CN1868485A Medicine composition and its application
11/29/2006	CN1868474A Ebastine tablet and its prepn. method
11/29/2006	CN1868464A Piduomode soft capsule and its prepn. method
11/29/2006	CN1868458A Controlled release composition and method of producing the same
11/29/2006	CN1868293A Sun flower type tea with eye-health and body-beautyifying
11/29/2006	CN1286835C Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/29/2006	CN1286821C 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
11/29/2006	CN1286815C Novel 4-anilinoquinoline-3-carboxamides compound
11/29/2006	CN1286527C Anti irritability Specificity Igy and its preparation
11/29/2006	CN1286465C Radix salviae miltiorrhizae oligosaccharide and its application for resisting acquired immunodeficiency syndrome, adjusting immunity and increasing leukocyte
11/28/2006	US7141656 In situ screening, isolation of peptides; major histocompability complex
11/28/2006	US7141653 Gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules; especially for treating asthma and other respiratory system disorders
11/28/2006	US7141651 Multiple cytokine protein complexes
11/28/2006	US7141648 Synthesis of cyclosporin analogs
11/28/2006	US7141599 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin
11/28/2006	US7141586 Nicotinamide derivatives useful as PDE4 inhibitors
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141574 Viral polymerase inhibitors
11/28/2006	US7141572 For therapy of osteoporosis, tumours, cachexia, atherosclerosis, rheumatoid arthritis, multiple sclerosis, diabetes mellitus, inflammatory processes, allergies, asthma, autoimmune diseases, myocardial diseases and AIDS
11/28/2006	US7141566 Benzoxazine and benzothiazine derivatives and the use thereof in medicaments
11/28/2006	US7141558 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
11/28/2006	US7141550 Intra-tumoral administration of IL-12 encoding nucleic acid molecules
11/28/2006	US7141363 Purposeful movement of human migratory cells away from an agent source
11/28/2006	US7141262 Using microfiltration and/or diafiltration to isolate transforming growth factor from dairy products for use in treatment and prevention of cell proliferative, autoimmune, bone and inflammatory disorders; antitumor agents
11/28/2006	CA2379786C Purine derivatives
11/28/2006	CA2375524C 3-(arylsulfonylamino)-tetrahydropyran-3-carboxylic acid hydroxamides
11/28/2006	CA2375513C 3-(arylsulfonylamino)-tetrahydrofuran-3-carboxylic acid hydroxamides
11/28/2006	CA2239853C Indane dimer compounds and their pharmaceutical use
11/28/2006	CA2160444C Aroyl-piperdine derivatives
11/28/2006	CA2026915C Stem cell factor
11/23/2006	WO2006125117A2 Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component
11/23/2006	WO2006123724A1 Novel pharmaceutical using anti-hla antibody
11/23/2006	WO2006123639A1 Pyrimidine derivative
11/23/2006	WO2006123550A1 Prophylactic or therapeutic agent for inflammatory disease
11/23/2006	WO2006123466A1 Drugs, food or drink for improving pancreatic functions
11/23/2006	WO2006123230A2 Compositions for antigen-specific induction of immuno-tolerance via oral immunization
11/23/2006	WO2006122792A1 Peptides capable of modulating the function of tirc7
11/23/2006	WO2006122791A2 Tirc7 as marker for detecting early immune activation
11/23/2006	WO2006122464A1 An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating b cell neoplasm
11/23/2006	WO2006122401A1 Negative regulation of nk cell functions by eat-2, a sap-related adaptor expressed in innate immune cells
11/23/2006	WO2006106437A3 Substituted oxazole derivatives and their use as tyrosine kinase inhibitors
11/23/2006	WO2006088833A3 Interleukin-17f antibodies and other il-17f signaling antagonists and uses therefor
11/23/2006	WO2006084015A3 Raf inhibitor compounds and methods
11/23/2006	US20060264609 Use of heat shock proteins
11/23/2006	US20060264493 Tetracyclic pyrazole derivatives as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them
11/23/2006	US20060264484 Fc receptor modulating compounds and compositions
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264464 Amidino compounds as cysteine protease inhibitors
11/23/2006	US20060264456 Phosphorus-containing compounds & uses thereof
11/23/2006	US20060264452 Analgesics; immunomodulators and for treatment of drug dependence; for example, 5'-Bromo-17-(cyclopropylmethyl)-6,7-didehydro-3,14-dihydroxy-4,5 alpha -epoxypyrido[2',3':6,7]morphinan
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	US20060264420 Tteating cell proliferation disease by modulation of kinesin and treatment of cancer
11/23/2006	US20060264403 phosphoric acid mono-[2-hydroxymethyl-4-(4-octyl-phenyl)-2-(1-oxo-1,3-dihydro-isoindol-2-yl)-butyl] ester; disorders mediated by lymphocytes interactions like transplant rejection, graft versus host disease, autoimmune diseases; binding affinity to Sphingosine-1-phosphate(S1P) receptors
11/23/2006	US20060264354 Cop 1 for treatment of inflammatory bowel diseases
11/23/2006	US20060263881 Methods of expanding and selecting disease associated T-Cells
11/23/2006	US20060263827 Novel endothelial cells, antibodies directed against said cells and use thereof, in particular for screening angiogenesis inhibiting substances
11/23/2006	US20060263819 Diagnostics and therapeutics for macular degeneration-related disorders
11/23/2006	US20060263430 instrument for inducing cytokine and method of inducing cytokine
11/23/2006	US20060263409 Treatment of ocular disease
11/23/2006	US20060263387 Vaccination of pigs against disease by administering a first recombinant porcine adenovirus vector stably expressing a heterologous nucleotide sequence encoding the antigenic determinant of the disease, preferably Hog Cholera Virus or Pseudorabies virus
11/23/2006	US20060263381 Peptide epitopes common to antigens of the same multigene family
11/23/2006	US20060263373 Utilization of an aminopeptidase inhibitor
11/23/2006	US20060263365 Method of immunomodulation
11/23/2006	DE102005023761A1 An die Lck-SH3 und Hck-SH3 Domäne bindende Peptide At the Lck-SH3 and SH3 domain binding peptides Hck
11/23/2006	DE102005023760A1 Synergistic antiallergic composition, useful for preventing or treating pollen allerginic reactions, comprises a drug combination of acetylsalicylic acid, salmeterol and topical corticosteroid
11/23/2006	DE102005022845A1 Thiobernsteinsäurederivate und deren Verwendung Thiobernsteinsäurederivate and their use
11/23/2006	CA2853335A1 Hivcon: an hiv immunogen and uses thereof
11/23/2006	CA2609067A1 An oligonucleotide or its functional homologue, a composition comprising the same and a method for treating b cell neoplasm
11/23/2006	CA2608750A1 Methods for diagnosis and treatment of diseases having an autoimmune and/or inflammatory component
11/23/2006	CA2605508A1 Blockade of pin1 prevents cytokine production by activated immune cells
11/22/2006	EP1724286A1 Variant CD44 polypeptide, polynucleotides encoding same, antibodies directed there against and method of using same for diagnosing and treating inflammatory diseases
11/22/2006	EP1724270A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/22/2006	EP1724267A1 Pyrimidine derivative
11/22/2006	EP1724264A1 Nitriles and medicinal compositions containing the same as the active ingredient

1 ... 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 ... 1172